Amgen Inc. (AMG HM) stock market data APIs
€323.768
1.31(0.4%)
as of March 12, 2026
Try our APIs with
free plan!
Amgen Inc. Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for AMG.HM.
Prev. Close
323.768
Open
325.08
High
325.08
Low
318.3803
52 wk Range
224.3994-331.05
Market Cap
105 182 M
Dividends (Yield)
0.0225
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Amgen Inc. data using free add-ons & libraries
Get Amgen Inc. Fundamental Data
Amgen Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Amgen Inc. News
New
Rapid Micro Biosystems Inc (RPID) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid ...
This article first appeared on GuruFocus. Release Date: March 12, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Rapid Mi...
Rapid Micro Biosystems Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance
Rapid Micro Biosystems, Inc. Reports record fourth quarter 2025 total revenue of $11.3 million, representing 37% growth compared to fourth quarter 2024 Reports full year 2025 total revenue of $33.6�...
Starbucks, Amgen, and CVS Help This Income Fund Shine
Hilda Applbaum, co-manager of the American Funds Income Fund of America, likes to buy inexpensive, high-yielding stocks poised for an upturn. Her strategy has trounced 98% of peers. Continue Reading
Assessing Whether Amgen (AMGN) Shares Look Mispriced After Recent Mixed Returns
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Why Amgen (AMGN) is on investors’ radar today Amgen (AMGN) is back in focus after...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
